🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

1,063 results for “BRIGHT MINDS BIOSCIENCES INC.” Clear

  1. Vigabatrin

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Addiction

    phase 3 small molecule completed

    2 trials

  2. Vivitrol

    BRIGHT MINDS BIOSCIENCES INC.

    Opiate Dependence

    phase 3 small molecule completed

    1 trial

  3. Vivitrol

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Dependence

    phase 3 small molecule completed

    2 trials

  4. Vivitrol

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid-use Disorder

    phase 3 small molecule completed

    1 trial

  5. Voucher-Based Reinforcement Therapy

    BRIGHT MINDS BIOSCIENCES INC.

    Substance-related Disorders

    phase 3 other completed

    1 trial

  6. XR-NTX

    BRIGHT MINDS BIOSCIENCES INC.

    Opiate Addiction

    phase 3 small molecule completed

    1 trial

  7. Zolpidem extended-release

    BRIGHT MINDS BIOSCIENCES INC.

    Drug Addiction

    phase 3 small molecule completed

    1 trial

  8. bicyclol, 25mg/ tablet

    BRIGHT MINDS BIOSCIENCES INC.

    Drug-Induced Acute Liver Injury

    phase 3 small molecule active

    1 trial

  9. cognitive-behavioral withdrawal regulation strategies

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Dependence

    phase 3 other active

    1 trial

  10. diflunisal

    BRIGHT MINDS BIOSCIENCES INC.

    Familial Amyloid Polyneuropathy

    phase 3 small molecule completed

    1 trial

  11. extended-release naltrexone (XR-NTX)

    BRIGHT MINDS BIOSCIENCES INC.

    Methamphetamine-dependence

    phase 3 small molecule active

    1 trial

  12. gentamicin

    BRIGHT MINDS BIOSCIENCES INC.

    Plague

    phase 3 small molecule completed

    1 trial

  13. injectable naltrexone

    BRIGHT MINDS BIOSCIENCES INC.

    Opiate Dependence

    phase 3 small molecule completed

    1 trial

  14. lorcaserin

    BRIGHT MINDS BIOSCIENCES INC.

    Obesity

    phase 3 small molecule terminated

    1 trial

  15. methadone

    BRIGHT MINDS BIOSCIENCES INC.

    HIV

    phase 3 small molecule completed

    1 trial

  16. naltrexone implant

    BRIGHT MINDS BIOSCIENCES INC.

    Heroin Dependence

    phase 3 small molecule completed

    1 trial

  17. nicotine transdermal system

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Use Disorder

    phase 3 small molecule completed

    2 trials

  18. strengths-based case management

    BRIGHT MINDS BIOSCIENCES INC.

    HIV

    phase 3 other completed

    1 trial

  19. tobacco abstinent contingent

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    phase 3 other completed

    1 trial

  20. 0% N2O

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid-Related Disorders

    phase 2 small molecule completed

    2 trials

  21. 1% tenofovir gel

    BRIGHT MINDS BIOSCIENCES INC.

    HIV Infections

    phase 2 small molecule completed

    1 trial

  22. 20% N2O

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid-Related Disorders

    phase 2 small molecule completed

    1 trial

  23. 30% Nitrous oxide

    BRIGHT MINDS BIOSCIENCES INC.

    Alcohol-Related Disorders

    phase 2 small molecule completed

    1 trial

  24. 413ABM

    BRIGHT MINDS BIOSCIENCES INC.

    MALARIA

    phase 2 other completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources